Document Detail


The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis.
MedLine Citation:
PMID:  2113929     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Controversy concerning the optimal treatment of endometriosis and its related infertility still exists. Thirty-one women with moderate and severe endometriosis, who failed to conceive during previous in-vitro fertilization and embryo transfer (IVF-ET) cycles (protocol A), were re-admitted for the procedure following a period of hormonal suppression with a gonadotrophin releasing-hormone (GnRH) agonist (protocol B). Following GnRH analogue treatment, a significantly higher number of oocytes were recovered (P less than 0.0006); consequently more embryos were transferred and significantly higher clinical pregnancy rates per cycle (P less than 0.0001) were achieved. This difference may be directly related to the beneficial effect of the GnRH analogue on pelvic endometriosis, converting severe cases into mild ones with improved ovarian accessibility and probably oocyte quality.
Authors:
D Dicker; G A Goldman; J Ashkenazi; D Feldberg; I Voliovitz; J A Goldman
Related Documents :
8988529 - Reproductive toxicity of ovulation induction.
8897119 - Dexamethasone as an adjuvant therapy for anovulatory, normoandrogenic patients during o...
18166179 - Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovar...
20602599 - Clinical outcome following stimulation with highly purified hmg or recombinant fsh in p...
20500109 - Human menopausal gonadotropin versus highly purified-hmg in controlled ovarian hypersti...
16895629 - Rescue of corpus luteum function with peri-ovulatory hcg supplementation in ivf/icsi gn...
7155029 - An improved method for preparation of semen for artificial insemination by husband.
12210579 - Prenatal diagnosis of female monozygotic twins discordant for turner syndrome: implicat...
21557919 - Relationship between late embryonic mortality and the increase in plasma advanced oxidi...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  5     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  1990 May 
Date Detail:
Created Date:  1990-08-08     Completed Date:  1990-08-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  418-20     Citation Subset:  IM    
Affiliation:
Sherman Fertility Institute, Golda Meir Medical Centre, Hasharon Hospital, Petah Tikva, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Buserelin / therapeutic use*
Embryo Transfer*
Endometriosis / complications*
Female
Fertilization in Vitro*
Humans
Infertility, Female / drug therapy*,  etiology
Oocytes / drug effects
Pregnancy
Chemical
Reg. No./Substance:
57982-77-1/Buserelin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endocrine changes in women conceiving during treatment with an LHRH agonist.
Next Document:  Serum levels of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG), a glycosylated beta...